Lynx1 Capital Management LP - Significant Ownership

Signature - Title
Weston Nichols - Chief Investment Officer
Location
San Juan, Puerto Rico
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Lynx1 Capital Management LP.

Significant Ownership of Lynx1 Capital Management LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PASG Passage BIO, Inc. Common Stock, par value $0.0001 per share 15% $5.25M 9.26M Lynx1 Capital Management LP Dec 31, 2024
TCRX TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share 10.9% $9.59M 5.36M Lynx1 Capital Management LP Dec 31, 2024
GHRS GH Research PLC Ordinary shares, nominal value $0.025 per share 10.2% $69.1M 6.35M Lynx1 Capital Management LP Feb 6, 2025
DTIL PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share 9.99% $4.31M 766K Lynx1 Capital Management LP Dec 31, 2024
ALLO Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share 5.2% $20.6M 10.9M Lynx1 Capital Management LP Dec 31, 2024

Schedules 13D/G Reported by Lynx1 Capital Management LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.